glp 1 direct to consumer GLP-1s Going Direct, How Novo and Lilly's DTC Strategy is Changing the Game for Patients and Plan Sponsors Informed or Influenced?: An Overview
Description
GLP-1 receptor agonists like semaglutide and tirzepatide work differently: they stimulate insulin secretion, slow gastric emptying, and reduce appetite through central nervous system signaling
It holds an active LegitScript certification, lists a verifiable San Francisco address, posts a clear HIPAA notice, and names two pharmacy partners (7 Cells and Drug Crafters), with patient choice in the portal
Source: Novo Investor Day 2022 Estimating the costs associated with diseases are inherently imprecise and noisy due to difficulties in normalising the difference between individual circumstances and lifestyles, but for the sake of providing ball-park figures, some studies have found that excess medical spending on obesity for adults is around 260 billion USD or around 1800 USD excess per person in 2019
Davies M, Pieber TR, Hartoft-Nielsen ML, et al
The more common risk on a GLP-1 is undereating, especially of protein
